| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2015-12-09^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf76406c97c582d9f98e3e81e501259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b168e38b88091a08a8ef06e5c5d8ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1f8aba81b23a312c9edb3207465348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c16a86796bd604db6357c62bc9e9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_969ce45c5c90f540a09fc8d0404ac88d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602baf2bbad1cbf64aa14e53ce755a84 |
| publicationDate |
2022-08-02^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114831988-A |
| titleOfInvention |
Quinoline derivatives for the treatment of non-small cell lung cancer |
| abstract |
The present application provides a quinoline derivative for treating non-small cell lung cancer. 1-[[[4-(4-Fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl provided in this application base] cyclopropylamine or a pharmaceutically acceptable salt thereof, can be used for the treatment of non-small cell lung cancer patients who are not suitable for EGFR-TKI therapy, and can significantly improve the treatment of non-small cell lung cancer patients who are not suitable for EGFR-TKI therapy compared with placebo progression-free survival. |
| priorityDate |
2014-12-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |